These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 38078667

  • 1. Giant lung cavity due to three different pathogens in a patient receiving inhaled salmeterol plus fluticasone propionate for asthma.
    Güner Zırıh NM, Yılmaz Kara B, Özyurt S, Okçu O, İlgar T, Şahin Ü.
    J Asthma; 2024 Jun; 61(6):643-648. PubMed ID: 38078667
    [Abstract] [Full Text] [Related]

  • 2. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA, Lyseng-Williamson KA, Wiseman LR.
    Drugs; 2005 Jun; 65(12):1715-34. PubMed ID: 16060707
    [Abstract] [Full Text] [Related]

  • 3. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P.
    Clin Drug Investig; 2010 Jun; 30(9):565-79. PubMed ID: 20593912
    [Abstract] [Full Text] [Related]

  • 4. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
    Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
    [Abstract] [Full Text] [Related]

  • 5. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 6. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008 Nov; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 7. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C, Naya I, Ekelund J.
    Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479
    [Abstract] [Full Text] [Related]

  • 8. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 01; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 9. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W, McKay AJ, Tudur Smith C, Williamson PR, James M, Price D, MASCOT Study Group.
    Health Technol Assess; 2013 Feb 01; 17(4):1-218. PubMed ID: 23380178
    [Abstract] [Full Text] [Related]

  • 10. Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma.
    Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA, Buaron KS, Yun Kirby S, Pascoe SJ, VESTRI Investigators.
    N Engl J Med; 2016 Sep 01; 375(9):840-9. PubMed ID: 27579634
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study.
    Bodzenta-Lukaszyk A, Dymek A, McAulay K, Mansikka H.
    BMC Pulm Med; 2011 May 23; 11():28. PubMed ID: 21605396
    [Abstract] [Full Text] [Related]

  • 12. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
    Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.
    Treat Respir Med; 2004 May 23; 3(3):173-81. PubMed ID: 15219176
    [Abstract] [Full Text] [Related]

  • 13. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar 23; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 14. Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone.
    Bailey W, Castro M, Matz J, White M, Dransfield M, Yancey S, Ortega H.
    Curr Med Res Opin; 2008 Jun 23; 24(6):1669-82. PubMed ID: 18462564
    [Abstract] [Full Text] [Related]

  • 15. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
    Allergy; 2003 Jul 23; 58(7):602-7. PubMed ID: 12823118
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma.
    Nugent C, Yiu G, Song S, Caracta C.
    J Asthma; 2018 Aug 23; 55(8):898-906. PubMed ID: 28933971
    [Abstract] [Full Text] [Related]

  • 17. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C, Wu EQ, Ray S, Colice GL.
    Clin Ther; 2009 Dec 23; 31(12):2779-803. PubMed ID: 20110019
    [Abstract] [Full Text] [Related]

  • 18. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA, Plosker GL.
    Pharmacoeconomics; 2003 Dec 23; 21(13):951-89. PubMed ID: 12959627
    [Abstract] [Full Text] [Related]

  • 19. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T, Adachi M.
    Nihon Rinsho; 2001 Oct 23; 59(10):1992-9. PubMed ID: 11676144
    [Abstract] [Full Text] [Related]

  • 20. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
    Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA, INSPIRE Investigators.
    Am J Respir Crit Care Med; 2008 Jan 01; 177(1):19-26. PubMed ID: 17916806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.